Young@Heart: empowering the next generation of cardiovascular researchers

M F Hoes1,2, A S J M Te Riele1,3, M M Gladka1,4,5

  • 1Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.

Insights

The Dutch CardioVascular Alliance (DCVA) supports early-career cardiovascular researchers through its Young@Heart initiative. This program aims to address challenges and leverage opportunities to reduce cardiovascular disease burden.

Area of Science:

  • Cardiovascular Research
  • Public Health Initiatives
  • Early-Career Researcher Development

Background:

  • Cardiovascular disease presents a significant and growing global health challenge.
  • The Dutch CardioVascular Alliance (DCVA) was established to address this burden, aiming for a 25% reduction by 2030.
  • The DCVA serves as a collaborative platform for diverse stakeholders in the cardiovascular field.

Purpose of the Study:

  • To outline the challenges and opportunities facing young cardiovascular researchers in the Netherlands.
  • To present the vision of the Young@Heart initiative in supporting and developing early-career researchers.
  • To foster collaboration and optimize potential within the young research community to combat cardiovascular disease.

Main Methods:

  • The article discusses the landscape for young researchers within the Dutch cardiovascular research ecosystem.
  • It highlights the role of the Young@Heart initiative as a support structure.
  • Qualitative insights into challenges and opportunities are presented.

Main Results:

  • Young cardiovascular researchers face specific hurdles in their early careers.
  • There are identifiable opportunities for growth and contribution within the field.
  • The Young@Heart initiative is positioned to facilitate researcher development and collaboration.

Conclusions:

  • Supporting young researchers is crucial for advancing cardiovascular disease prevention and treatment.
  • Optimizing collaborations through initiatives like Young@Heart can accelerate progress.
  • The collective efforts of early-career researchers are vital to achieving the DCVA's ambitious goals for reducing cardiovascular disease burden.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
655
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.2K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.8K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
410